Search Result "dose-schedule"
Bevacizumab in the Treatment of Glioblastoma: Is there an Optimal Dose or Schedule?
Ebook: Controversies in Neuro-Oncology
Volume: 1 Year: 2010
Author(s): L. Kamsheh, P. Kumthekar, J. J. Raizer
Doi: 10.2174/978160805132811001010054
Optimizing Antitumor Efficacy and Adverse Effects of Pegylated Liposomal Doxorubicin by Scheduled Plasmapheresis: Impact of Timing and Dosing
Journal: Current Drug Delivery
Volume: 15 Issue: 9 Year: 2018 Page: 1261-1270
Author(s): Romeo Ngoune,Christine Contini,Michael M. Hoffmann,Dominik von Elverfeldt,Karl Winkler,Gerhard Putz
Scheduling of Taxanes: A Review
Journal: Current Clinical Pharmacology
Volume: 5 Issue: 3 Year: 2010 Page: 226-231
Author(s): Emma J. Woodward, Chris Twelves
Can Targeted Therapy be Successful without Metronomic Scheduling ?
Journal: Current Topics in Medicinal Chemistry
Volume: 12 Issue: 15 Year: 2012 Page: 1639-1642
Author(s): Nicolas Andre,Eddy Pasquier,Barton Kamen
Peak and Trough Concentrations of Gentamicin in the Neonate: A Review of the Literature
Journal: Current Pediatric Reviews
Volume: 5 Issue: 1 Year: 2009 Page: 2-7
Author(s): Gian Maria Pacifici
Topotecan and Irinotecan in the Treatment of Pediatric Solid Tumors
Journal: Current Pediatric Reviews
Volume: 1 Issue: 1 Year: 2005 Page: 55-61
Author(s): Yoshiaki Tsuchida, Toshiji Shitara
Radiation Therapy Plus Angiogenesis Inhibition with Bevacizumab: Rationale and Initial Experience
Journal: Reviews on Recent Clinical Trials
Volume: 2 Issue: 3 Year: 2007 Page: 163-168
Author(s): Carsten Nieder, Nicole Wiedenmann, Nicolaus H. Andratschke, Sabrina T. Astner, Michael Molls
Review of Postoperative and Elective Nodal Irradiation in Head and Neck Cancer
Journal: Current Cancer Therapy Reviews
Volume: 10 Issue: 4 Year: 2014 Page: 291-304
Author(s): Daniel M. Trifiletti,Austin Sim,David D. Wilson,Paul W. Read
The Years of Creativity: 1953-1965. Pre-Clinical
Ebook: THERAPEUTIC REVOLUTION The History of Medical Oncology from Early Days to the Creation of the Subspecialty
Volume: 1 Year: 2014
Author(s): Pierre R. Band
Doi: 10.2174/9781608058143114010009
The Design of Clinical Trials for New Molecularly Targeted Compounds: Progress and New Initiatives
Journal: Current Pharmaceutical Design
Volume: 8 Issue: 2 Year: 2002 Page: 2279-2284
Author(s): Lesley Seymour